Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

The influence of cyclosporine a and rapamycin on the b cell subpopulations in vitro

P Wierzbicki, M Jastrzębska, D Kłosowska, A Korecka, G Korczak-Kowalska, A Górski

Ann Transplant 2009; 14(1): 69-69 :: ID: 880452

Abstract

Background: Data on the influence of immunosuppressive drugs on the generation and functions of the B cell subpopulations including B-1a, B1b, and conventional B2 are limited. B1 cells are important cell population producing natural antibodies and involved in antibacterial humoral responses. Among them B1a subset expresses the pan-T cell surface glycoprotein CD5. This molecule is known to modulate lymphocyte activation and differentiation processes. Compared to B2 cells, B1a are long-lived, non-circulating, with reduced BCR affinity.
Material/Methods: The aim of this study was to compare the effects of two
commonly used immunosuppressive drugs, i.e. cyclosporine A (a calcineurine inhibitor) and rapamycin (a cell division inhibitor), on the induction of the B cell subpopulations. Mononuclear cells were obtained from the whole peripheral blood of healthy blood donors. PBMCs were cultured for five days in the presence or absence of either drug. Then the percentages of CD19, CD11b, and CD5 positive cells on PWM-activated and non-activated cells were determined using appropriate monoclonal antibodies. Flow cytometry was performed with a FACSCalibur (BD Biosciences) and data were analyzed using Cell Quest software.
Results: Although both investigated drugs decreased the percentages of B-1a and B1b cells, the difference was statistically significant only in the B-1a subpopulation. On the other hand, neither drug affected the percentage of B2 cells.
Conclusions: The present study is preliminary and we intend to pursue this
line of research by evaluating the influence of immunosuppressive drugs on the functions of the major B cell subpopulations, especially their capability to produce antibodies.

Keywords: Immunosuppression

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358